← All stocks

GMED vs SNN

Globus Medical Inc. Class A Common Stock vs Smith & Nephew SNATS Inc. Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

ACCE scores
GMED
SNN
Composite score
Out of 100
56
50
Growth
28
40
Value
72
75
Quality
78
67
Momentum
46
17
Valuation
GMED
SNN
Price
74.08
27.56
Market cap
9.95B
11.53B
Trailing P/E
18.95
18.75
Forward P/E
13.91
11.19
EV / EBITDA
9.92
9.23
Dividend yield
0.0%
2.9%
Profitability
GMED
SNN
ROE
11.8%
11.8%
Net margin
17.0%
10.1%
Debt / equity
0.00
0.59
Free cash flow
588.77M
852.00M
Growth
GMED
SNN
Revenue growth (YoY)
5.9%
4.6%
Earnings growth (YoY)
-26.2%
5.7%
Analyst target
103.23
32.89
See full analysis